Final answer:
Aldesleukin (IL-2) is a medication used in clinical settings for the treatment of certain types of cancer, such as metastatic renal cell carcinoma and metastatic melanoma. It is a form of immunotherapy that stimulates the immune system to fight cancer cells.
Step-by-step explanation:
Aldesleukin, also known as IL-2, is a medication used in clinical settings for the treatment of certain types of cancer, such as metastatic renal cell carcinoma and metastatic melanoma. It is a form of immunotherapy that stimulates the immune system to fight cancer cells. IL-2 works by activating T lymphocytes, a type of white blood cell, to target and destroy cancer cells. While effective in some cases, it can have significant side effects and is typically used when other treatments have not been successful.